FDA Inspection 551423 — Medtronic Heart Valves Division

Medtronic Heart Valves Division — FEI 2025587

The FDA completed an inspection of Medtronic Heart Valves Division on Dec 19, 2008 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 19, 2008
Fiscal Year
2009
Product Type
Devices
Project Area
Compliance: Devices
Location
Santa Ana, CA (United States)

Citations

IDCFRDescription
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
325021 CFR 820.72(b)(2)Calibration documentation
330121 CFR 820.100(a)(2)Investigation procedures
368921 CFR 820.100(a)(2)Investigation
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.